Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers

被引:13
作者
Fernandes, Ana R. [1 ]
Santos, Ana C. [1 ,3 ]
Sanchez-Lopez, Elena [4 ,5 ]
Kovacevic, Andjekla B. [1 ]
Espina, Marta [4 ,5 ]
Calpena, Ana C. [5 ,6 ]
Veiga, Francisco J. [1 ,2 ]
Garcia, Maria L. [4 ,5 ]
Souto, Eliana B. [1 ,2 ]
机构
[1] Univ Coimbra FFUC, Fac Pharm, Dept Pharmaceut Technol, Coimbra, Portugal
[2] Univ Coimbra FFUC, Fac Pharm, REQUIMTE LAQV, Grp Pharmaceut Technol, Coimbra, Portugal
[3] Inst Mol & Cell Biol, Inst Innovat & Hlth Res, Grp Genet Cognit Dysfunct, Porto, Portugal
[4] Univ Barcelona, Dept Phys Chem, Fac Pharm, Barcelona, Spain
[5] Univ Barcelona, Inst Nanosci & Nanotechnol IN2UB, Fac Pharm, Barcelona, Spain
[6] Univ Barcelona, Dept Biopharm & Pharmaceut Technol, Fac Pharm, Barcelona, Spain
关键词
Nonmelanoma skin cancers; Basal cell carcinoma; Squamous cell carcinoma; Actinic keratosis; Novel oral targeted therapies; Clinical trials; SQUAMOUS-CELL CARCINOMA; RENAL-TRANSPLANT RECIPIENTS; PHASE-I CHEMOPREVENTION; INGENOL MEBUTATE GEL; ACTINIC KERATOSES; DOUBLE-BLIND; TOPICAL TREATMENT; RECURRENCE RATES; RETINOIC ACID; XERODERMA-PIGMENTOSUM;
D O I
10.1159/000479529
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Neoplastic skin lesions are multifocal, diffuse skin infiltrations of particular relevance in the differential diagnosis of ulcerative, nodular, or crusting skin lesions. Nonmelanoma skin cancers (NMSCs), namely, basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and also actinic keratosis (AK), are the most common malignant tumors in humans. BCCs do not proliferate rapidly and most of the times do not metastasize, while SCCs are more infiltrative, metastatic, and destructive. AKs are precursor lesions of cutaneous SCCs. The classical therapy of NMSCs makes use of photodynamic therapy associated with chemotherapeutics. With improved understanding of the pathological mechanisms of tumor initiation, progression, and differentiation, a case is made towards the use of targeted chemotherapy with the intent to reduce the cytotoxicity of classical treatments. The present review aims to describe the current state of the art on the knowledge of NMSC, including its risks factors, oncogenes, and skin carcinogenesis, discussing the classical therapy against new therapeutic options. (C) 2017 S. Karger AG, Basel
引用
收藏
页码:59 / 73
页数:15
相关论文
共 126 条
[1]   Serum lipid profile in oral squamous cell carcinoma: alterations and association with some clinicopathological parameters and tobacco use [J].
Acharya, S. ;
Rail, P. ;
Hallikeri, K. ;
Anehosur, V. ;
Kale, J. .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2016, 45 (06) :713-720
[2]   CLINICAL-EVALUATION OF TOPICAL ISOTRETINOIN IN THE TREATMENT OF ACTINIC KERATOSES [J].
ALIREZAI, M ;
DUPUY, P ;
AMBLARD, P ;
KALIS, B ;
SOUTEYRAND, P ;
FRAPPAZ, A ;
SENDAGORTA, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1994, 30 (03) :447-451
[3]  
[Anonymous], 2016, Skin cancer
[4]   Effectiveness of 5-fluorouracil treatment for actinic keratosis - a systematic review of randomized controlled trials [J].
Askew, Deborah A. ;
Mickan, Sharon M. ;
Soyer, Peter ;
Wilkinson, David .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2009, 48 (05) :453-463
[5]   A Randomized, Double-Blind, Placebo-Controlled Phase 3 Skin Cancer Prevention Study of α-Difluoromethylornithine in Subjects with Previous History of Skin Cancer [J].
Bailey, Howard H. ;
Kim, KyungMann ;
Verma, Ajit K. ;
Sielaff, Karen ;
Larson, Paul O. ;
Snow, Stephen ;
Lenaghan, Theresa ;
Viner, Jaye L. ;
Douglas, Jeff ;
Dreckschmidt, Nancy E. ;
Hamielec, Mary ;
Pomplun, Marcy ;
Sharata, Harry H. ;
Puchalsky, David ;
Berg, Eric R. ;
Havighurst, Thomas C. ;
Carbone, Paul P. .
CANCER PREVENTION RESEARCH, 2010, 3 (01) :35-47
[6]   (-)-epigallocatechin-3-gallate inhibition of ultraviolet B induced AP-1 activity [J].
Barthelman, M ;
Bair, WB ;
Stickland, KK ;
Chen, WX ;
Timmermann, N ;
Valcic, S ;
Dong, ZG ;
Bowden, GT .
CARCINOGENESIS, 1998, 19 (12) :2201-2204
[7]   PREVENTION OF SKIN-CANCER AND REDUCTION OF KERATOTIC SKIN-LESIONS DURING ACITRETIN THERAPY IN RENAL-TRANSPLANT RECIPIENTS - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY [J].
BAVINCK, JNB ;
TIEBEN, LM ;
VANDERWOUDE, FJ ;
TEGZESS, AM ;
HERMANS, J ;
TERSCHEGGET, J ;
VERMEER, BJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (08) :1933-1938
[8]   Retinoids in the chemoprevention of non-melanoma skin cancers: why, when and how [J].
Bettoli, Vincenzo ;
Zauli, Stefania ;
Virgili, Anna .
JOURNAL OF DERMATOLOGICAL TREATMENT, 2013, 24 (03) :235-237
[9]  
BOLLAG W, 1970, Agents and Actions, V1, P172, DOI 10.1007/BF01965758
[10]   Non-melanoma skin cancer: what drives tumor development and progression? [J].
Boukamp, P .
CARCINOGENESIS, 2005, 26 (10) :1657-1667